American Alpha Advisors, LLC

Position in BMY — Bristol Myers Squibb Co

CIK 2041441 NEW YORK, NY

Position in BMY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$650,126

-$33,278 QoQ

Shares Held

11,283

+0.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.05%

of 13F equity value

Holder Rank

#1,398

of 2,506 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

American Alpha Advisors, LLC holds $3,152,792 across 5 Drug Manufacturers - General names. BMY ranks #3 (20.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	5,707	$733,349
2	AMGN	Amgen Inc	1,839	$665,938
3	BMY	Bristol Myers Squibb Co This page	11,283	$650,126
4	GILD	Gilead Sciences, Inc.	4,542	$573,836
5	PFE	Pfizer Inc	21,991	$529,543

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$650,126	11,283	+0.1%	Shares	Sole	2026-08-14
2026-03-31	$683,404	11,268	+3.4%	Shares	Sole	2026-05-15
2025-12-31	$587,622	10,894	+14.4%	Shares	Sole	2026-02-17
2025-09-30	$429,306	9,519	+0.4%	Shares	Sole	2025-10-29
2025-06-30	$438,736	9,478	+12.1%	Shares	Sole	2025-08-07
2025-03-31	$515,670	8,455	-7.3%	Shares	Sole	2025-05-12
2024-12-31	$515,883	9,121	-6.2%	Shares	Sole	2025-02-11
2024-09-30	$502,912	9,720	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.